Comparison of Safety and Efficacy of Insulin Glargine and Neutral Protamine Hagedorn Insulin in Older Adults with Type 2 Diabetes Mellitus: Results from a Pooled Analysis

Pearl Lee; Annette Chang; Caroline Blaum; Aleksandra Vlajnic; Ling Gao; Jeffrey Halter

doi:10.1111/j.1532-5415.2011.03773.x

Comparison of Safety and Efficacy of Insulin Glargine and Neutral Protamine Hagedorn Insulin in Older Adults with Type 2 Diabetes Mellitus: Results from a Pooled Analysis

Journal of the American Geriatrics Society ◽

10.1111/j.1532-5415.2011.03773.x ◽

2012 ◽

Vol 60 (1) ◽

pp. 51-59 ◽

Cited By ~ 33

Author(s):

Pearl Lee ◽

Annette Chang ◽

Caroline Blaum ◽

Aleksandra Vlajnic ◽

Ling Gao ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Older Adults ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Pooled Analysis ◽

Safety And Efficacy ◽

Neutral Protamine Hagedorn

Download Full-text

Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis

BMJ Open ◽

10.1136/bmjopen-2015-009421 ◽

2016 ◽

Vol 6 (2) ◽

pp. e009421 ◽

Cited By ~ 35

Author(s):

Nick Freemantle ◽

Engels Chou ◽

Christian Frois ◽

Daisy Zhuo ◽

Walter Lehmacher ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Basal Insulin ◽

Meta Analysis ◽

Safety And Efficacy

Download Full-text

How do insulin glargine and insulin detemir compare with neutral protamine Hagedorn (NPH) insulin for adults with type 2 diabetes mellitus?

Cochrane Clinical Answers ◽

10.1002/cca.3515 ◽

2021 ◽

Author(s):

Adarsh Gupta

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Insulin Detemir ◽

Nph Insulin ◽

Neutral Protamine Hagedorn

Download Full-text

Safety and efficacy of a basal-plus regimen with insulin glargine and insulin glulisine for elderly patients with high cardiovascular risk and type 2 diabetes mellitus

Revista Clínica Española (English Edition) ◽

10.1016/j.rceng.2017.02.004 ◽

2017 ◽

Vol 217 (4) ◽

pp. 201-206

Author(s):

R. Gómez-Huelgas ◽

J. Sabán-Ruiz ◽

F.J. García-Román ◽

N. Quintela-Fernández ◽

J.M. Seguí-Ripoll ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cardiovascular Risk ◽

Elderly Patients ◽

Insulin Glargine ◽

High Cardiovascular Risk ◽

Safety And Efficacy ◽

Insulin Glulisine

Download Full-text

Safety and Efficacy of High Versus Standard Starting Doses of Insulin Glargine in Overweight and Obese Chinese Individuals with Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Medications (Beyond VII): Study Protocol for a Randomized Controlled Trial

Advances in Therapy ◽

10.1007/s12325-018-0717-x ◽

2018 ◽

Vol 35 (6) ◽

pp. 864-874 ◽

Cited By ~ 4

Author(s):

Linong Ji ◽

Zhengnan Gao ◽

Bimin Shi ◽

Rongwen Bian ◽

Fuzai Yin ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Controlled Trial ◽

Safety And Efficacy ◽

Randomized Controlled ◽

Oral Antidiabetic

Download Full-text

Insulin Glargine Combined with Oral Antidiabetic Drugs for Asians with Type 2 Diabetes Mellitus: A Pooled Analysis to Identify Predictors of Dose and Treatment Response

Diabetes Therapy ◽

10.1007/s13300-018-0381-9 ◽

2018 ◽

Vol 9 (2) ◽

pp. 771-787 ◽

Cited By ~ 3

Author(s):

Tianwei Gu ◽

Ting Hong ◽

Pengzi Zhang ◽

Sunyinyan Tang ◽

Yan Bi ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Treatment Response ◽

Pooled Analysis ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

Safety and efficacy of teneligliptin in Japanese patients with type 2 diabetes mellitus: a pooled analysis of two Phase III clinical studies

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2015.1032249 ◽

2015 ◽

Vol 16 (7) ◽

pp. 971-981 ◽

Cited By ~ 23

Author(s):

Takashi Kadowaki ◽

Fuyuhiko Marubayashi ◽

Shoko Yokota ◽

Makoto Katoh ◽

Hiroaki Iijima

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Clinical Studies ◽

Japanese Patients ◽

Pooled Analysis ◽

Phase Iii ◽

Two Phase ◽

Safety And Efficacy

Download Full-text

Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study

BMJ Open ◽

10.1136/bmjopen-2012-002348 ◽

2013 ◽

Vol 3 (4) ◽

pp. e002348 ◽

Cited By ~ 27

Author(s):

Li Wang ◽

Wenhui Wei ◽

Raymond Miao ◽

Lin Xie ◽

Onur Baser

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Real World ◽

Database Study ◽

Neutral Protamine Hagedorn ◽

Retrospective Database

Download Full-text

Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies

Journal of Medical Economics ◽

10.3111/13696998.2013.824458 ◽

2013 ◽

Vol 16 (9) ◽

pp. 1137-1145 ◽

Cited By ~ 9

Author(s):

Lin Xie ◽

Wenhui Wei ◽

Chunshen Pan ◽

Onur Baser

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Real World ◽

Observational Studies ◽

Pooled Analysis

Download Full-text

Comparison of Incidence of Acute Myocardial Infarction in Patients With Type 2 Diabetes Mellitus Following Initiation of Neutral Protamine Hagedorn Insulin Versus Insulin Glargine

The American Journal of Cardiology ◽

10.1016/j.amjcard.2009.05.030 ◽

2009 ◽

Vol 104 (7) ◽

pp. 910-916 ◽

Cited By ~ 13

Author(s):

George G. Rhoads ◽

Mikhail Kosiborod ◽

Richard W. Nesto ◽

Vivian A. Fonseca ◽

Shou-En Lu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Myocardial Infarction ◽

Type 2 Diabetes ◽

Acute Myocardial Infarction ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Neutral Protamine Hagedorn

Download Full-text

Abstract #209 Phase 4 Study of Safety and Efficacy of The First Anti-Inflammatory Drug Approved in India in Type 2 Diabetes Mellitus (Hydroxychloroquine) - A Preliminary Evaluation

Endocrine Practice ◽

10.1016/s1530-891x(20)47055-7 ◽

2018 ◽

Vol 24 ◽

pp. 31-32

Author(s):

Anilkumar Pareek ◽

Nitin Chandurkar ◽

Ravi Mehta ◽

Kumar Naidu

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Preliminary Evaluation ◽

Safety And Efficacy ◽

Inflammatory Drug ◽

Anti Inflammatory

Download Full-text